Connect your AI

Geron GERN Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

Syndax PharmaceuticalsSNDX

$56K-50.0%

CelcuityCELC

$1.25M+127%

Cogent Biosciences, Inc.COGT

$278K—

Other financials

Income statement

Revenue$51.8M+30.9%

Operating income$158.0K+101%

Net income-$3.6M+81.6%

EPS (diluted)-$0.01+66.7%

Balance sheet

Cash & equivalents$48.7M-12.2%

Total debt$134.0M+10.0%

Total equity$229.1M-14.6%

Total assets$534.1M-5.0%

Cash flow

Operating cash flow-$62.9M-31.1%

CapEx$206.0K+2.0%

Free cash flow-$43.8M-6.8%

Valuation

Market cap$878.88M-8.6%

Enterprise value$964.15M-6.2%

P/S4.7×-172×

Profitability

Operating margin-705.5%-351pp

Net margin-682.5%-339pp

FCF margin-734.4%-365pp

Returns & leverage

Return on equity-27.1%-7.8pp

Debt / equity0.6×+0.1×

Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Geron's debt issuance cost amortization?: Geron (GERN) reported debt issuance cost amortization of $286K in Q1 2026.
How has Geron's debt issuance cost amortization changed year-over-year?: Geron's debt issuance cost amortization increased by 13.0% year-over-year, from $253K to $286K.
What is the long-term trend for Geron's debt issuance cost amortization?: Over 4 years (2021 to 2025), Geron's debt issuance cost amortization has grown at a 4.6% compound annual growth rate (CAGR), from $893K to $1.07M.
What does debt issuance cost amortization mean?: Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).